SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000905148-09-003630
Filing Date
2009-12-03
Accepted
2009-12-03 17:08:57
Documents
1
Period of Report
2009-11-11

Document Format Files

Seq Description Document Type Size
1 efc9-1068_ex.html 3  
1 efc9-1068_ex.xml 3 5147
  Complete submission text file 0000905148-09-003630.txt   7710
Mailing Address 405 EAGLEVIEW BOULEVARD EXTON PA 19341
Business Address 405 EAGLEVIEW BOULEVARD EXTON PA 19341 484-713-6000
Fibrocell Science, Inc. (Issuer) CIK: 0000357097 (see all company filings)

IRS No.: 870458888 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 21700 OXNARD ST SUITE 1520 WOODLAND HILLS CA 91367-7584
Business Address 21700 OXNARD ST SUITE 1520 WOODLAND HILLS CA 91367-7584 8188838270
AKANTHOS CAPITAL MANAGEMENT LLC (Reporting) CIK: 0001218957 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-31564 | Film No.: 091220786

Mailing Address 21700 OXNARD STREET SUITE 1520 WOODLAND HILLS CA 91367-7584
Business Address
Michael Kao (Reporting) CIK: 0001452251 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-31564 | Film No.: 091220785